Objectives

After participating in this educational activity, attendees should be able to:
1. Review the latest evidence shaping our understanding of the period of infectivity of SARS-CoV-2
2.Understand the mechanism of molecular tests (RT-PCR) for SARS-CoV-2
3. Understand the limitations of antibody testing and Baystate's plans for studies of this modality    

Faculty
Franklin Moore, MD, PhD
Pathology Department - Baystate

Sarah Haessler, MD, MS
Vice Chair for Clinical Affairs - Department of Medicine
Associate Professor - UMMS-Baystate

Megan Gallagher, MD
Infectious Disease Specialist - Baystate Medical Center 

Faculty Disclosure  
   The design and content of Baystate Continuing Interprofessional Education ( CE ) activities support quality improvement in healthcare and provide fair and balanced views of therapeutic options.  Faculty or planner conflicts of interest are resolved before the educational activity.   

Planning Committee Member Dr. Skiest is receives grant/research support through Gilead, Pfizer, GlaxoSmith Kline      

None of the other members of the faculty and planning committee for this educational event have commercial relationships with any entity producing, marketing, re-selling or distributing health care goods and services consumed by or used on patients.

  

Session date: 
Wednesday, June 10, 2020 - 8:00am to 9:00am
Location: 
Baystate Medical Center
759 Chestnut St.
Springfield, MA 01199
United States
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 ANCC Contact Hours
  • 1.00 BCIPE Instructional Hours

Please login or register to take this course.